Quality over quantity - rethinking social participation in dementia prevention: results from the AgeWell.de trial.

Covid-19 Dementia Lifestyle intervention Prevention Randomized controlled trial Social participation

Journal

Social psychiatry and psychiatric epidemiology
ISSN: 1433-9285
Titre abrégé: Soc Psychiatry Psychiatr Epidemiol
Pays: Germany
ID NLM: 8804358

Informations de publication

Date de publication:
09 Sep 2024
Historique:
received: 26 04 2024
accepted: 28 08 2024
medline: 10 9 2024
pubmed: 10 9 2024
entrez: 9 9 2024
Statut: aheadofprint

Résumé

Social participation as a protective factor against cognitive decline was one of the targets in the AgeWell.de study, a multi-domain interventional trial in a sample of older adults at increased risk for dementia. This study aimed to examine differential effects of the intervention and other influencing factors on social participation throughout the trial. A longitudinal analysis of study data at the primary follow-up after 24 months (n = 819) was conducted. The Lubben Social Network Scale (LSNS-6) was used to assess quantitative aspects of social networks, and self-reported social activities were classified using a three-tiered categorical framework to capture qualitative aspects. A positive effect of the intervention was observed at the qualitative framework level, with an OR of 1.38 [95% CI: 1.05-1.82] for achieving or maintaining higher social participation at follow-up, while no effect could be detected on quantitative social network characteristics. Later phases of the Covid-19 pandemic showed a negative impact on the level of social participation at follow-up with an OR of 0.84 [95% CI: 0.75-0.95]. These findings suggest that by focusing on qualitative aspects of social participation as a component of dementia prevention, future interventions can promote enriched social interactions within established social networks. German Clinical Trials Register (DRKS) ID DRKS00013555.

Sections du résumé

BACKGROUND BACKGROUND
Social participation as a protective factor against cognitive decline was one of the targets in the AgeWell.de study, a multi-domain interventional trial in a sample of older adults at increased risk for dementia. This study aimed to examine differential effects of the intervention and other influencing factors on social participation throughout the trial.
METHODS METHODS
A longitudinal analysis of study data at the primary follow-up after 24 months (n = 819) was conducted. The Lubben Social Network Scale (LSNS-6) was used to assess quantitative aspects of social networks, and self-reported social activities were classified using a three-tiered categorical framework to capture qualitative aspects.
RESULTS RESULTS
A positive effect of the intervention was observed at the qualitative framework level, with an OR of 1.38 [95% CI: 1.05-1.82] for achieving or maintaining higher social participation at follow-up, while no effect could be detected on quantitative social network characteristics. Later phases of the Covid-19 pandemic showed a negative impact on the level of social participation at follow-up with an OR of 0.84 [95% CI: 0.75-0.95].
CONCLUSIONS CONCLUSIONS
These findings suggest that by focusing on qualitative aspects of social participation as a component of dementia prevention, future interventions can promote enriched social interactions within established social networks.
TRIAL REGISTRATION BACKGROUND
German Clinical Trials Register (DRKS) ID DRKS00013555.

Identifiants

pubmed: 39251412
doi: 10.1007/s00127-024-02757-4
pii: 10.1007/s00127-024-02757-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s).

Références

Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S et al (2020) Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 396(10248):413–446
doi: 10.1016/S0140-6736(20)30367-6 pubmed: 32738937 pmcid: 7392084
Penninkilampi R, Casey AN, Singh MF, Brodaty H (2018) The Association between Social Engagement, loneliness, and risk of dementia: a systematic review and Meta-analysis. J Alzheimers Dis 66(4):1619–1633
doi: 10.3233/JAD-180439 pubmed: 30452410
Sommerlad A, Kivimaki M, Larson EB, Rohr S, Shirai K, Singh-Manoux A et al (2023) Social participation and risk of developing dementia. Nat Aging 3(5):532–545
doi: 10.1038/s43587-023-00387-0 pubmed: 37202513
Ngandu T, Lehtisalo J, Solomon A, Levalahti E, Ahtiluoto S, Antikainen R et al (2015) A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 385(9984):2255–2263
doi: 10.1016/S0140-6736(15)60461-5 pubmed: 25771249
Zülke A, Luck T, Pabst A, Hoffmann W, Thyrian JR, Gensichen J et al (2019) AgeWell.de - study protocol of a pragmatic multi-center cluster-randomized controlled prevention trial against cognitive decline in older primary care patients. BMC Geriatr 19(1):203
doi: 10.1186/s12877-019-1212-1 pubmed: 31370792 pmcid: 6670136
Röhr S, Zülke A, Luppa M, Brettschneider C, Weißenborn M, Kühne F et al (2021) Recruitment and baseline characteristics of participants in the AgeWell.de Study-A pragmatic cluster-randomized controlled Lifestyle Trial against Cognitive decline. Int J Environ Res Public Health. ;18(2)
Zülke AE, Pabst A, Luppa M, Roehr S, Seidling H, Oey A et al (2023) A multidomain intervention against cognitive decline in an at-risk-population in Germany: results from the cluster-randomized AgeWell.de trial. Alzheimers Dement
MacLeod S, Tkatch R, Kraemer S, Fellows A, McGinn M, Schaeffer J et al (2021) COVID-19 era social isolation among older adults. Geriatr (Basel). ;6(2)
Lubben J, Blozik E, Gillmann G, Iliffe S, von Renteln Kruse W, Beck JC et al (2006) Performance of an abbreviated version of the Lubben Social Network Scale among three European community-dwelling older adult populations. Gerontologist 46(4):503–513
doi: 10.1093/geront/46.4.503 pubmed: 16921004
Lubben JE (1988) Assessing social networks among elderly populations. Fam Community Health 11(3):42–52
doi: 10.1097/00003727-198811000-00008
Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I et al (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53(4):695–699
doi: 10.1111/j.1532-5415.2005.53221.x pubmed: 15817019
Sheikh JI, Yesavage JA (1986) Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Gerontologist: J Aging Mental Health 5(1–2):165–173
Gauggel S, Birkner B (1999) Validität Und Reliabilität Einer Deutschen Version Der Geriatrischen Depressionsskala (GDS). Z für Klinische Psychologie Und Psychother 28(1):18–27
doi: 10.1026//0084-5345.28.1.18
Kelly ME, Duff H, Kelly S, McHugh Power JE, Brennan S, Lawlor BA et al (2017) The impact of social activities, social networks, social support and social relationships on the cognitive functioning of healthy older adults: a systematic review. Syst Reviews 6(1):259
doi: 10.1186/s13643-017-0632-2
Wendel F, Bauer A, Blotenberg I, Brettschneider C, Buchholz M, Czock D et al (2022) Social Network and Participation in Elderly Primary Care patients in Germany and associations with depressive Symptoms-A cross-sectional analysis from the AgeWell.de Study. J Clin Med 11:19
doi: 10.3390/jcm11195940
Levasseur M, Richard L, Gauvin L, Raymond E (2010) Inventory and analysis of definitions of social participation found in the aging literature: proposed taxonomy of social activities. Soc Sci Med 71(12):2141–2149
doi: 10.1016/j.socscimed.2010.09.041 pubmed: 21044812 pmcid: 3597625
Luster JE, Ratz D, Wei MY (2022) Multimorbidity and Social Participation is moderated by purpose in life and life satisfaction. J Appl Gerontol 41(2):560–570
doi: 10.1177/07334648211027691 pubmed: 34225497
Siren AL, Seppanen M, von Bonsdorff MB (2023) Social Participation considered as meaningful in old age - the perceptions of senior housing residents in Finland. Ageing Int. :1–21
Tolksdorf K, Loenenbach A, Buda S (2022) Dritte Aktualisierung Der „Retrospektiven Phaseneinteilung Der COVID-19-Pandemie in Deutschland. Epid Bull 2022 38:3–6
Schonlau M HOTDECKVAR: Stata module for hotdeck imputation. Statistical Software Components S458527, Boston College Department of Economics2018, revised 19 April 2022
Naqvi A (2023) Stata package sankey
Seckman C (2023) The impact of COVID-19 on the psychosocial well-being of older adults: a literature review. J Nurs Scholarsh 55(1):97–111
doi: 10.1111/jnu.12824 pubmed: 36218196
Carstensen LL (2021) Socioemotional selectivity theory: the role of perceived endings in human motivation. Gerontologist 61(8):1188–1196
doi: 10.1093/geront/gnab116 pubmed: 34718558 pmcid: 8599276
Schroder D, Heesen G, Heinemann S, Hummers E, Jablonka A, Steffens S et al (2022) Development and validation of a questionnaire to Assess Social Participation of High Risk-Adults in Germany during the COVID-19 pandemic. Front Public Health 10:831087
doi: 10.3389/fpubh.2022.831087 pubmed: 35558532 pmcid: 9086897
Beutel ME, Klein EM, Brähler E, Reiner I, Jünger C, Michal M et al (2017) Loneliness in the general population: prevalence, determinants and relations to mental health. BMC Psychiatry 17(1):97
doi: 10.1186/s12888-017-1262-x pubmed: 28320380 pmcid: 5359916
Dahlberg L (2021) Loneliness during the COVID-19 pandemic. Aging Ment Health 25(7):1161–1164
doi: 10.1080/13607863.2021.1875195 pubmed: 33491474
Smith ML, Steinman LE, Casey EA (2020) Combatting social isolation among older adults in a time of physical distancing: the COVID-19 Social Connectivity Paradox. Front Public Health 8:403
doi: 10.3389/fpubh.2020.00403 pubmed: 32850605 pmcid: 7396644

Auteurs

Robert P Kosilek (RP)

Institute of General Practice and Family Medicine, University Hospital, LMU Munich, Munich, Germany. robert_philipp.kosilek@med.uni-muenchen.de.
Institute and Clinic for Occupational, Social and Environmental Medicine, University Hospital, LMU Munich, Munich, Germany. robert_philipp.kosilek@med.uni-muenchen.de.

Flora Wendel (F)

Institute for Medical Information Processing, Biometry and Epidemiology (IBE), LMU Munich, Munich, Germany.

Isabel Zöllinger (I)

Institute of General Practice and Family Medicine, University Hospital, LMU Munich, Munich, Germany.

Hanna Lea Knecht (HL)

German Centre for Neurodegenerative Diseases (DZNE), site Rostock/Greifswald, Greifswald, Germany.

Iris Blotenberg (I)

German Centre for Neurodegenerative Diseases (DZNE), site Rostock/Greifswald, Greifswald, Germany.

Solveig Weise (S)

Institute of General Practice and Family Medicine, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.

Thomas Fankhänel (T)

Institute of General Practice and Family Medicine, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.

Juliane Döhring (J)

Institute of General Practice, University of Kiel, Kiel, Germany.

Martin Williamson (M)

Institute of General Practice, University of Kiel, Kiel, Germany.

Melanie Luppa (M)

Institute of Social Medicine, Occupational Health and Public Health (ISAP), Medical Faculty, University of Leipzig, Leipzig, Germany.

Andrea E Zülke (AE)

Institute of Social Medicine, Occupational Health and Public Health (ISAP), Medical Faculty, University of Leipzig, Leipzig, Germany.

Christian Brettschneider (C)

Department of Health Economics and Health Service Research, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Birgitt Wiese (B)

Work Group Medical Statistics and IT-Infrastructure, Institute for General Practice, Hannover Medical School, Hannover, Germany.

Wolfgang Hoffmann (W)

German Centre for Neurodegenerative Diseases (DZNE), site Rostock/Greifswald, Greifswald, Germany.
Institute for Community Medicine, University Medicine Greifswald (UMG), Greifswald, Germany.

Thomas Frese (T)

Institute of General Practice and Family Medicine, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany.

Hans-Helmut König (HH)

Department of Health Economics and Health Service Research, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Hanna Kaduszkiewicz (H)

Institute of General Practice, University of Kiel, Kiel, Germany.

Jochen René Thyrian (JR)

German Centre for Neurodegenerative Diseases (DZNE), site Rostock/Greifswald, Greifswald, Germany.
Institute for Community Medicine, University Medicine Greifswald (UMG), Greifswald, Germany.
Faculty V: School of Life Sciences, University of Siegen, Siegen, Germany.

Steffi G Riedel-Heller (SG)

Institute of Social Medicine, Occupational Health and Public Health (ISAP), Medical Faculty, University of Leipzig, Leipzig, Germany.

Jochen Gensichen (J)

Institute of General Practice and Family Medicine, University Hospital, LMU Munich, Munich, Germany.

Classifications MeSH